课题基金 / 基金详情

Induction of mucosal immune responses by DNA vaccine encoding Porphyromonas gingivalis fimbriae

Induction of mucosal immune responses by DNA vaccine encoding Porphyromonas gingivalis fimbriae
编码牙龈卟啉单胞菌菌毛的 DNA 疫苗诱导粘膜免疫反应
批准号:
12671769
负责人:
KAWABATA Shigetada
金额:
$2.37万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

KAWABATA Shigetada的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
For the development of vaccines against oral and pharyngeal pathogens invading the mucosal epithelia, both secretory and serum IgA/IgG antibodies and cytotoxic T lymphocytes have been induced. We employed a novel approach, targeted salivary gland (TSG) immunization, using a plasmid pcDNA3/fimA coding for Porphyromonas gingivalis fimbriae. Expression of subunit protein, fimbrillin, was observed in eukaryotic cells growing in vitro following transfection, with pcDNA3/fimA. In this study, we obtained good humoral and cell-mediated immune responses in BALB/c mice by TSG administration using the above mentioned DNA vaccine. The production 6f fimbriae-specific IgA and IgG antibodies in saliva and serum IgG antibody was significantly stimulated by TSG immunization. Injection of DNA vaccine into salivary gland elicited high level production of antigen-specific IgG antibody, similar to that induced following intramuscular immunization. The major IgG subclass that recognized fimbriae was IgG2a in serum from pcDNA3/fimA immunized mice. When mononuclear cells from salivary glands^were analyzed by RT-PCR, higher levels of Th2 cytokine-specific mRNA were seen in the immunized group than non-immunized group. In addition, TSG DNA immunization resulted in the generation of antigen-specific CTL in spleen. These results indicate that TSG immunization with plasmid DNA may represent a genetic immunization strategy against infection by oral and pharyngeal pathogens that may invade local, mucosal surfaces.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
川端 重忠(分担): "歯周病(新しい治療を求めて)"先端医療技術研究所. 536 (2000)
Shigetada Kawabata(撰稿人):“牙周疾病(寻找新的治疗方法)”先进医疗技术研究所 536(2000)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nakagawa et al.: "Functional differences among FimA variants of Porphyromonas gingivalis and their effects on adhesion to and invasion of human epithelial cells"Infect. Immun.. 70. 277-285 (2002)
Nakakawa 等人:“牙龈卟啉单胞菌 FimA 变体的功能差异及其对人类上皮细胞粘附和侵袭的影响”感染。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nakagawa I. et al.: "Functional differences among FimA variants of Porphyromonas gingivalis and their effects on adhesion to and invasion of human epithelial cells"Infection and Immunity. 70. 277-285 (2002)
Nakakawa I. 等人:“牙龈卟啉单胞菌 FimA 变体之间的功能差异及其对人类上皮细胞粘附和侵袭的影响”感染和免疫。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
8
    Exploration of bacterial factors that inactivate complement regulatory factors and induce invasive infectious diseases
    • 批准号:
      24390410
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.48万
    • 财政年份:
      2012
    • 负责人:
      KAWABATA Shigetada
    • 依托单位:
    Functional analysis of adhesins and colonization factors produced by human pathogenic streptococci
    • 批准号:
      20390465
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.4万
    • 财政年份:
      2008
    • 负责人:
      KAWABATA Shigetada
    • 依托单位:
    Protective immunity against group Astreptococcus infection following immunization with fibronectin-binding proteins
    • 批准号:
      18390489
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.84万
    • 财政年份:
      2006
    • 负责人:
      KAWABATA Shigetada
    • 依托单位:
    Molecular mimic of group A streptococcal surface proteins
    • 批准号:
      16390525
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.15万
    • 财政年份:
      2004
    • 负责人:
      KAWABATA Shigetada
    • 依托单位:
    海外基金